Germline Mutations in SMAD4 Disrupt Bone Morphogenetic Protein Signaling
Authors:
- Fadi S. DahdalehFDFadi S. Dahdaleh
- Donghong WangDWDonghong Wang
- James R. HoweJHJames R. Howe
- 1 May 2012
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 174 (2) , 211-214
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Bone Morphogenetic Proteins and CancerNeurosurgery, 2010
- The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposisClinical Genetics, 2008
- Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-like Activity and Antagonize Activin and MyostatinJournal of Biological Chemistry, 2008
- Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 PromoterJournal of Biological Chemistry, 2002
- Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4Oncogene, 2000
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Mutations in the SMAD4/DPC4 Gene in Juvenile PolyposisScience, 1998
- A Gene for Familial Juvenile Polyposis Maps to Chromosome 18q21.1The American Journal of Human Genetics, 1998
- An Overview of Epithelio-Mesenchymal TransformationCells Tissues Organs, 1995
- Bone: Formation by AutoinductionScience, 1965